Skip to main content
. 2010 Dec;25(6):601–613. doi: 10.1089/cbr.2010.0865

Table 4.

Key Differences Between World Health Organization and Immune-Related Response Criteria

  WHO criteria irRC
New lesions Always mean progressive disease Incorporated into measurement of total tumor burden that determines response
Progressive disease ≥25% increase in sum of products of diameters at any time ≥25% increase in sum of products of diameters, confirmed by repeat scans at least 4 weeks later

WHO, World Health Organization; irRC, immune-related response criteria.